Home page > Coronavirus

Edit email address
Invalid email
Email Sent
Chiesi Group is closely monitoring the COVID-19 outbreak and is acting in order to make the health and wellbeing of patients and employees a priority. Dedicated teams across our network are taking measures to protect the continuous supply of our medicines in all countries and implemented strict guidelines to ensure the safety of all employees across the Chiesi Group in line with government policies and needs and following the WHO recommendations. We are committed to our focus on improving the quality of human life and put people at the center of our actions, to protect the health and wellbeing of our employees, patients and partners.
Patients & our people: Putting the safety of our people first
Chiesi has put in place an Emergency Management Team constantly monitoring the evolving scenario and taking daily actions in compliance with the indications given by Institutions and by the World Health Organization, to protect the health and safety of all Chiesi Employees. Protecting, sharing, informing and training are the pillars of the work carried out by the team. In order to protect the health of our employees we have punt in place extraordinary measures: employees working from home, and those going to work every day in our premises thanks to stringent measures in all of our production facilities and in our research centers ensuring the highest safety standards.

Chiesi has put in place all the necessary measures to ensure the continuity of our services, whilst prioritizing and protecting the health of our employees, patients and partners.
Partners: Protecting our partners and supply chains
Our production lines in Parma and those abroad (in France and Brazil) are continuing to operate and all necessary Chiesi people for the business continuity of our Company are being supported with the necessary tools and conditions to work safely, both from home or directly at our sites. A team of experts are dedicated to continued monitoring of our supply chains and business continuity plans and contingencies are in place in order to protect the supply of medicines in all the countries where Chiesi's products are distributed, in particular for those without any therapeutic alternative on the market.
Products and R&D: Continued commitment to supply and innovation
Our Business Continuity Team is working to ensure that we can continue to produce and provide an adequate stock of materials and products to avoid market supply disruptions for our products, especially for those without any therapeutic alternative on the Market. At this time, we are able to continue to deliver products as normal, and all of our production plants continue to work as scheduled. Our R&D work also continues at our numerous research and development sites globally.
Our Efforts in Italy
Volunteering associations
Correction facilities
Institutions and public bodies
Donations in Italy
Protective gowns
Pair of gloves
medical equipment
sanitizing gel
290.634 €
worth of medicinal

Total: 2.588.355 €